Here's Why Acrivon Therapeutics, Inc. (ACRV) Is a Great 'Buy the Bottom' Stock Now

Core Viewpoint - Acrivon Therapeutics, Inc. (ACRV) has experienced a 14% decline in stock price over the past week, but a hammer chart pattern suggests a potential trend reversal as buying interest may be emerging to counteract selling pressure [1][2]. Technical Analysis - The hammer chart pattern indicates a possible bottoming out, with reduced selling pressure, suggesting that bulls may be regaining control [2][5]. - The hammer pattern is characterized by a small candle body and a long lower wick, indicating that the stock opened lower, reached a new low, but closed near or above the opening price, reflecting buying interest [4][5]. - This pattern can occur across various timeframes and is utilized by both short-term and long-term investors [5]. Fundamental Analysis - Recent upward revisions in earnings estimates for ACRV serve as a bullish indicator, correlating strongly with near-term stock price movements [7]. - The consensus EPS estimate for ACRV has increased by 3.4% over the last 30 days, indicating strong agreement among analysts regarding improved earnings potential [8]. - ACRV holds a Zacks Rank of 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which typically outperform the market [9].